Critical shortage of vaccine that prevents painful skin rash, nerve damage



[ad_1]



ATLANTA – The C-D-C is a warning of a shortage of a vaccine, which is taken to prevent a painful viral infection that causes skin rashes and nerve pain.

"The bread from shingles lasts weeks, and you could end up with bread that lasts months even years." said Dr. Kathleen Dooling, CDC Medical Officer.

Shingles, which usually strikes people fifty years and older, is a reactivation of the chicken pox virus, which most of us get when we are children.

"Ninety-nine percent of people have had chicken pox, so they remember it so, if you are over fifty, chances are you are at risk of getting shingles." said Dr. Dooling.


TRENDING STORIES:


Last year, drug maker GlaxoSmithKline won government approval Shingles vaccine Shingles. It has a ninety percent success rate at preventing Shingles. Demand for the vaccine has soared, so much so, the company can not make it fast enough.

"Demand has definitely exceeded expectations, and exceeded supply of the vaccine." said Dr. Dooling.

The vaccine is administered in two injections, two to six months apart. The CDC is one of the providers, including doctors and pharmacies, to give first consideration to those who have already recieved their first dose, in dispensing the drug.

The vaccine injections may cause temporary effects, including swelling and muscle aches, but the CDC says the pain is minimal when compared to the long lasting discomfort of shingles, and the potential for nerve damage.

For more information on Shingles vaccine availability, the CDC advises checking vaccinfinder.org

[ad_2]
Source link